Fusion Robotics receives FDA 510(k) clearance for spinal navigation & robotics system
BOULDER -- Fusion Robotics LLC, a spinal robotics and navigation company, announced receiving 510(k) clearance to market the company’s 3D imaging compatible navigation and robotic targeting... Read More
Friday February 26, 2021 0 comments
New COVID-19 antibody test receives emergency use authorization by FDA
DENVER --Scientists at the University of Denver have tested a new antibody test for COVID-19 that can predict if a patient will experience mild versus more severe symptoms of the virus. The... Read More
Thursday February 4, 2021 0 comments
Ampio gets FDA feedback on proposed modifications to special protocol assessment for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced it received guidance from the U.S Food Drug Administration regarding the impact of COVID-19 on its Phase III clinical... Read More
Wednesday December 30, 2020 0 comments
Clovis Oncology submits Investigational New Drug applications to FDA for FAP-2286 for therapeutic and imaging clinical trial
BOULDER -- Clovis Oncology, Inc. (NASDAQ: CLVS) today announced it has completed submission of two Investigational New Drug (IND) applications to the U.S. Food and Drug Administration (FDA) for... Read More
Tuesday December 29, 2020 0 comments
Ampio enters into collaborative research agreements to explore additional clinical indications for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug,... Read More
Monday December 14, 2020 0 comments
SomaLogic announces FDA collaboration to advance biosimilar development
BOULDER -- SomaLogic, Inc . announced an agreement with the U.S. Food and Drug Administration’s Division of Applied Regulatory Science to evaluate the utility of large-scale analysis of proteins... Read More
Monday November 2, 2020 0 comments
FDA grants IND and approves clinical trial protocol of inhaled Ampion for COVID-19 patients
ENGLEWOOD-- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it has received an Investigational New Drug designation from the U.S. Food and Drug Administration, allowing the company to... Read More
Monday September 21, 2020 0 comments
FDA grants orphan drug designation to AmideBio for treatment of congenital hyperinsulinism
BOULDER -- AmideBioLLC , a privately held biopharmaceutical company, announced that the U.S. Food and Drug Administration Office of Orphan Products Development granted an orphan drug designation to... Read More
Friday April 24, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
